Snowball will help you to track your portfolio, plan deposits to your brokerage account and support your passive income strategy with tools and community of investors
What sector does Shanghai Fosun Pharmaceutical Group Co Ltd (2196) operate in?
Shanghai Fosun Pharmaceutical Group Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Shanghai Fosun Pharmaceutical Group Co Ltd (2196) current stock price?
As of the latest data, Shanghai Fosun Pharmaceutical Group Co Ltd stock price is HK$28.80, with a previous close of HK$27.26. Shanghai Fosun Pharmaceutical Group Co Ltd gained HK$1.54 in the last trading session, representing a 5.65% increase.
What is Shanghai Fosun Pharmaceutical Group Co Ltd (2196) current market capitalization?
Shanghai Fosun Pharmaceutical Group Co Ltd market cap is approximately 15.90 billion.
What is Shanghai Fosun Pharmaceutical Group Co Ltd (2196) Earnings Per Share (EPS)?
The trailing EPS is HK$1.22, and the forward EPS is HK$1.26.
What is Shanghai Fosun Pharmaceutical Group Co Ltd (2196) Price-to-Earnings (P/E) ratio?
Shanghai Fosun Pharmaceutical Group Co Ltd current P/E ratio is 23.61, with a forward P/E of 22.86.
What is Shanghai Fosun Pharmaceutical Group Co Ltd (2196) EBITDA?
Shanghai Fosun Pharmaceutical Group Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 1.80 billion.
Does Shanghai Fosun Pharmaceutical Group Co Ltd (2196) pay dividends?
Yes. Shanghai Fosun Pharmaceutical Group Co Ltd pays annual dividends with an annualized yield of 1.22% and an estimated annual payout of HK$0.35 per share.
When is the next ex-dividend date for Shanghai Fosun Pharmaceutical Group Co Ltd (2196)?
The next ex-dividend date is scheduled for July 24, 2026.
How did Shanghai Fosun Pharmaceutical Group Co Ltd (2196) perform in its most recent earnings report?
In the last report (June 30, 2025), Shanghai Fosun Pharmaceutical Group Co Ltd posted an EPS surprise of -3.33% and a revenue surprise of -2.15%.
When is Shanghai Fosun Pharmaceutical Group Co Ltd (2196) next earnings report?
Shanghai Fosun Pharmaceutical Group Co Ltd is expected to release its next earnings report on September 30, 2025.
What is Shanghai Fosun Pharmaceutical Group Co Ltd (2196) beta (volatility) score?
Shanghai Fosun Pharmaceutical Group Co Ltd has a beta of 0.669, indicating lower volatility than the overall market.
